Reimbursed with a limitationOriginator productATC L01FE02

Vectibix

Vectibix is an originator product from Amgen Switzerland AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 426.90 to CHF 1'658.40 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Amgen Switzerland AG
ATC code
L01FE02
IT group
07.16.10 Cytostatica
Active substances
Panitumumabum
Preparation type
Originator product
On the SL since
01/05/2010
Last price change
01/12/2019
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Vectibix Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Inf Konz 100 mg/5mlDurchstf 5 mlCHF 377.45CHF 426.9001/05/2010A7680578720017
Inf Konz 400 mg/20mlDurchstf 20 mlCHF 1'509.81CHF 1'658.4001/07/2013A7680578720031

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/12/2019

Nur nach vorgängiger Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes:
Zur Behandlung von Patienten mit metastasierendem kolorektalem Karzinom mit RAS-Wildtyp
- In der First-Line-Therapie in Kombination mit FOLFOX oder FOLFIRI.
- In der Second-Line-Therapie in Kombination mit einer Irinotecan-haltigen Chemotherapie.
- Als Monotherapie, wenn Therapien mit Fluoropyrimidin-, Oxaliplatin- und Irinotecan-haltigen Chemotherapien versagt haben oder nicht durchführbar waren.
Im Falle einer Progression ist die Vectibix-Behandlung abzubrechen.

FAQ

Is Vectibix covered by Swiss health insurance?

Yes, but only under conditions. Vectibix is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Vectibix cost in Switzerland?

The public price is the maximum price set by the FOPH and for Vectibix ranges from CHF 426.90 to CHF 1'658.40 per pack. The ex-factory price ranges from CHF 377.45 to CHF 1'509.81. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com